Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-340-8 | CAS number: 28182-81-2
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Additional information
The toxicological database for inhaled Hexamethylene diisocyanate, oligomers (biuret) demonstrates consistently that toxicity is associated only with the portal of entry (respiratory tract), any other manifestations of toxicity are secondary to this. While no fertility studies are available for Hexamethylene diisocyanate, oligomers (biuret), subchronic and subacute studies all show toxicity confined to the respiratory tract. Fertility studies with other aliphatic diisocyanates (H12MDI and HDI) show no effects on reproductive parameters, all effects are confined to the respiratory tract. Hence the databases for other aliphatic diisocyanates (IPDI, H12MDI and HDI) all show that primary toxicity for diisocyanates is to the respiratory tract, other effects, such as fetotoxicity in developmental studies, are secondary to this. This relationship applies to H12MDI and HDI when tested in fertility studies in the rat and is considered to apply equally to Hexamethylene diisocyanate, oligomers (biuret), i.e., if any effects were to be seen in a fertility study, these would occur only as a secondary effect of the toxicity to the respiratory system of the exposed rats. Protection against respiratory tract toxicity will protect against any secondary effects.
Using the weight of evidence, it is concluded that reproductive toxicity is not an endpoint of concern for Hexamethylene diisocyanate, oligomers (biuret) and additional toxicity testing is not necessary.
Effects on developmental toxicity
Additional information
The toxicological database for inhaled Hexamethylene diisocyanate, oligomers (biuret) demonstrates consistently that toxicity is associated only with the portal of entry (respiratory tract), any other manifestations of toxicity are secondary to this. While no developmental study is available for Hexamethylene diisocyanate, oligomers (biuret), subchronic and subacute (and acute) studies all show toxicity confined to the respiratory tract. Hence the databases for other aliphatic diisocyanates (IPDI, H12MDI, HDI) all show that primary toxicity for diisocyanates is to the respiratory tract, other effects, such as fetotoxicity in developmental studies, are secondary to this. This relationship applies to IPDI, H12MDI and HDI when tested in developmental toxicity studies in the rat and is considered to apply equally to Hexamethylene diisocyanate, oligomers (biuret), i.e., if any effects were to be seen in a developmental study, these would occur only as a secondary effect of the toxicity to the respiratory system of the exposed rats. Protection against respiratory tract toxicity will protect against any secondary effects.
Using the weight of evidence, it is concluded that developmental toxicity is not an endpoint of concern for Hexamethylene diisocyanate, oligomers (biuret) and additional toxicity testing is not necessary.
Justification for classification or non-classification
No classification required for toxicity to reproduction according to Regulation (EC) No 1272/2008, Annex I.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
